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THE existence of carcinogens of biological origin was demonstrated for the
first time by Shabad (1937) who induced sarcoma in mice by injecting lipoid
extracts from post-mortem human tissues. His discovery was confirmed by a
number of other investigators (des Ligneris, 1940; Hieger, 1940; Steiner, 1941;
Sannie. Truhaut, Guerin and Guerin, 1941) who found that sarcomas in mice
resulted from the subcutaneous injection of cholesterol-rich extracts, e.g. (1) the
unsaponifiable part of the fatty fraction of liver, kidney, muscle or lung of human
subjects who had died of cancer or of some other cause, or (2) the unsaponifiable
fraction from the brain and spinal cord of cattle. The succeeding steps in this work
showed that cholesterol itself, even when highly purified had carcinogenic activity
(Hieger, 1947, 1949, 1957; Hieger and Orr, 1954). In a recent publication,
Hieger (1957) describes an experiment in which 11 mice developed sarcoma out
of 115 (initially) injected mice; ifthe incidence is calculated on the number ofmice
which survived to the minimal latent period (thus cancelling out from the initial
number all mice which died early and were not at risk) the incidence amounted
to 14 per cent. The cholesterol in this experiment was highly purified (Schwenk
process) and administered as a 10per cent solution in olive oil prepared by heating
on the water bath. In control experiments where the solvent alone was injected
into mice, (lard was used as solvent in the earlier tests and controls), 5 sarcomas
d<eveloped in a total of 1122 treated mice (Table I).
TABLE I.-Control Tests on Solvents Injected Subcutaneously into Mice
Survivors
(months)
Strain of Numbar -
Solvent mice at start 12 18 24 Sarcomas
Lard stock Lad d . .. stock 366 159 81 16 . 1
,, . . . . .057 f
,, . .. . . stock 100 47 20 2 0
Olive oil . .C 134 90 45 6 . 1
,. . .... stock 50 . 33 12 2 . 0
,, . . ...... ,, . 50 .24 13 0. 0
,, . . . ...,, .. 66 . 14 1 0 . 0
,, .. . ....,, . 56 . 47 20 1 . 1
"...... * C57 · 50 39 28 13.
,, .58 .52 33 7 0 stockf'
Tricaprylin C57 · 30 17 6 2 1
Stearic acid + olive oil . stock 51 32 13 2 0
Tristearin + olive oil (5 30). ,, 50 . 33 13 3 . 1
Sesame oil . .61 46 13 4 . 0
Total 1122 5I. HIEGER
The reports ofthe carcinogenic activity of cholesterol have provoked comment
and criticism. For example, (1) it has been objectedthat since cholesterolispresent
in all tissues of the body and particularly in atheromatous arteries, cancer should
be expected to occur in all tissues and particularly at atheromatous sites. (II) A
second criticism takes another form; since cholesterol is found in all tissues but
cancer does not appear in every tissue, the carcinogenic activity of cholesterol
when injected into mice could be due to an active derivative formed from the
cholesterol by some reactions peculiar to the conditions of the experiment. (III)
A third objection suggests that as the threshold carcinogenic dose of benzpyrene
for the mouse is ofthe order ofonly a microgram the activity of cholesterol in the
mouse experiments could be due to contamination with a minute trace of a potent
carcinogen of the type of benzpyrene. (IV) A fourth comment points out the
difficulty ofreconciling the negative results obtained by other workers who tested
cholesterol by more or less the same technique which gave positive results in
Hieger's experiments. (V) Fifthly, the idea has been put forward that since
watery suspensions of cholesterol have proved negative when tested for carcino-
genic activity and since in tests giving positive results the cholesterol is heated
with oily solvent at water bath temperature for up to 2 hours before the solution
is injected, chemical changes could well take place during the heating which
might at least contribute to the carcinogenic activity of the solution.
These five questions will now be discussed.
(I) Cholesterol present in all tissues of the body
Cholesterol is found associated with fat in all tissues and particularly in
atheromatous aortas, yet cancer in man develops at sites of which the aorta is
one of the least common. The apparent contradiction between this fact and the
positive mouse tests on cholesterol is by no means insoluble. Urethane when
given to mice in the drinking water or painted on the skin, gives rise to tuinours
of the lung only; /-naphthylamine when inhaled or absorbed through the skin
by men working in the dye and rubber industries causes cancer of the bladder
and not ofother organs; benzpyrene applied in large doses over a space ofseveral
years failed to induce cancer in the skin ofthe monkey. When discussing carcino-
genic action, the tissue, and the species of animal to which it belongs as well as
the type of carcinogen must all be taken into consideration. The human aorta
contains very little cellular tissue which may well be resistant to carcinogenesis
by cholesterol. The inferences which can be made from the work on cholesterol
are not intended to suggest that all human cancer is mediated by cholesterol, no
such crude hypothesis is propounded here, the illustrations just quoted merely
show that the opposite conclusion has not been established.
(II) Injected cholesterol as the precursor of a carcinogen
In its simplest form, question (II) suggests that although cholesterol itself is a
normal chemical component of the tissues, when it is injected subcutaneously in
oily solution it is slowly converted to some active derivative which is the true
carcinogen.
This possibility gains support from Bischoff's experiments on the reported
carcinogenic capacity of oxidative derivatives of cholesterol which he obtained as
a by-product in the preparation of progesterone by the oxidation of cholesterol
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with permanganate. The mixtureofcompoundsresultingfromthereactioninduced
sarcomas on injection subcutaneously into mice of the Buffalo strain. From this
result Fieser et al. (1955) concluded that the active agent in carcinogenesis by
cholesterol was some ketonic derivative (e.g. A4-cholestene-3-one) or a chemically
active isomer, namely, lathosterol (A7-cholestenol). Fieser et al. (1955), Bischoff
and Rupp (1946), Bischoff, Lopez and Rupp (1954), and Bischoff et al. (1955)
reported that a number of derivatives of cholesterol when injected in batches of
30 Buffalo mice induced 19-60 per cent offibrosarcomas. The most potent member
of this group of compounds was 6,8-hydroperoxy-A4-cholestene-3-one. They state
that purified cholesterol was found inactive but that unpurified cholesterol had
some carcinogenic potency.
"Administered in sesame oil, impure cholesterol lathosterol, and the non-
keto fraction of cholesterol oxidized by oxygen in soap suspension produced
higher incidences of fibrosarcoma than controls which received only sesame
oil or sesame oil plus pure cholesterol or cholestenone."
The results of Bischoff and his colleagues are summarised in Table II.
TABLE II.-Oxidative Derivates of Cholesterol as Carcinogenic agents
(Fieser, et al., 1955; Bischoff, et. al., 1955)
Per cent fibrosarcomas
Compound tested (in groups of 33 Buffalo mice)
none, control . . 0
6-hydroxy-A4-cholestene-3-one. . 19
A4-cholestene-3,6-dione . . 34
none, control . . 0
cholesteryl oxide . . 43
6-hydroperoxy-A4-cholestene-3-one . 60
Some of the compounds reported to be strongly carcinogenic by Fieser and
Bischoff have been tested in the writer's laboratory. The yield of tumours does
not confirm the statement ofthe Americanworkers thatthese oxidative derivatives
are more potent carcinogens than cholesterol, neither can we agree with their
pronouncement on the lack of potency of cholesterol. It must be noted however
that different strains of mice were used in the two laboratories.
In an earlier paper (Hieger, 1959) giving the results ofexperiments in progress
it was stated that none of the compounds tested had at that stage produced
sarcomas; the experiments are now almost completed and a number of tumours
have developed, 5 of them in the series of mice injected with hydroperoxide.
The results are shown in Table III; they indicate that (1) under our conditions
only the hydroperoxide of all the oxidative derivatives of cholesterol has given
evidence ofany appreciable carcinogenic activity; (2) mice ofC57 strain are more
sensitive than stock mice, but this difference probably depends to some extent
on their longer life span. The same difference of response between C57 and stock
mice was observed when two parallel series were tested with cholesterol purified
by the Schwenk process (Table IV). Although C57 mice were used for the tests
on A5: cholestene-3-one and lathosterol, the yield of tumours totalled a single
sarcoma; the crude KMnO4 oxidation product, A4-cholestene-3: 6-dione and
6-hydroxy-A4-cholestene-3-one were not tested on C57 mice and it is possible that
they too might have given some positive results under such conditions.
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TABLE III.-Sarcoma Induction by Derivatives of Cholesterol
Survivors
(months)
Number of mice A-
Compound and strain 12 15 18 21 24 30 Sarcomas
CrudeKMnO4 oxidationproduct ofcholesterol stock 50 . 24 17 14 3 1 0 . 0
A4-cholestene-3: 6-dione (in olive oil) .. ,, 55 . 31 22 16 8 4 0 . 0
6f-hydroperoxy-A4-cholestene-3-one (in olive
oil) . . . . ,, 55 . 28 22 18 11 5 0. 0
(In sesame oil) . ,, 65 . 32 27 22 14 6 - . 0
,, . . . . . ,, 51 .34 31 15 8 2 -. 0
,,.9. . .. Buffalo 36. 7 4 2 1 0 -. 1
,,9 * * * * C57 50. 46393823 15 . 4
6-hydroxy-A4-cholestene-3-one (in olive oil). stock 50 . 35 26 13 9 0 - 1
(in sesame oil) . .. ,, 54 . 30 23 21 4 0 - . 1 A5-cholestene-3-one (in olive oil) . . ,, 40 . 14 12 8 4 0 - . 0
,, · ·* C57 50 .38 34 29 23 11 - . 1
Lathosterol . . . C57 50 . 39 - 17 - 5 - . 0
TABLE IV.-Sarcoma Induction by Purified Cholesterol (Schwenk Process)




mice Strain 12 18 24 30 Sarcomas
57 . Stock .25 14 5 1. 0
50 · C57 47 31 24 7 . 3 (latent periods
12, 18, 24 months)
Asfaras the results go they suggestthat thehydroperoxide andpure cholesterol
have about the same order of carcinogenic activity (Tables III and IV) which
gives no support to the idea expressed by Fieser et al. (1955), and is implicit in
the writings of Bischoff et al. (1955), that cholesterol is a pre-carcinogen when
injected into the mouse and has to be converted to an oxidised carcinogenic deri-
vative before it can induce sarcoma.
(III) Trace contamination by carcinogens of hydrocarbon type
The experiments designed to test lipoid tissue-extracts and the earlier tests
with cholesterol before 1950 were carried out in a room at the Chester Beatty Insti-
tute where some other series of mice were being treated with potent carcinogens
such as benzpyrene, thus introducing the possibility of contamination. In 1950
all the experiments on carcinogenesis by lipoids and steroids were transferred to
our country laboratories, twenty miles out of London, where the atmosphere is
less smoky and where there are arrangements for housing the mice in rooms un-
contaminated by carcinogens other than cholesterol (Hieger and Orr, 1954).
Nevertheless, it soon became clear that even if all reasonable precautions were
taken to avoid contamination, cholesterol still induced sarcoma in mice. In order
to obtain some data on the degree of contamination which might appreciably
affect the yield of sarcomas with cholesterol alone, series of mice were given small
doses of benzpyrene to find where the threshold dose ofbenzpyrene lay (Table V).
The results ofthe experiments detailed in Table V suggest that (1) the threshold
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of benzpyrene in the region of 10 y would have to be injected along with the
cholesterol in order to give ayield ofsarcomas appreciably higher than what would
be expected with cholesterol alone, (3) the sensitivity of mice to small doses of
benzpyrene can vary by a factor of at least 5 to 1.
TABLE V.-Threshold Dose of Benzpyrene Requiredfor Sarcoma Induction
No. of Total dose ofbenzpyrene
mice at (in 10% cholesterol: How No. of
Experiment start Strain 90% olive oil) administered sarcomas
1 . 50 . C57 . 004 y in a single dose . 0
2 .,,.,,. 04 y . ,, 1
3 . , .,,. 40 y . ,, 5
4 . .. 40 0 y . 23
5 . stock . 7.5 y .divided in 6 injections. 2
6 .,,.,,. 0 75y . ,, . 3
7 .0... 0.075y ,, . 3
8 . ... 50 y 19
9 . ... 5 y . ,, . 3
10 .,,.,,. 05 y . . 0
11 .,, . ,, .
,, .
0 12....0.",
13 .. 1, . ,, . 1
14 . ,, . C57 10 y . . 10
15 . ,, stock . 10 y in single dose . 6
Ifit be assumed as a working hypothesis that sensitivity is proportional to the
yield of tumours and inversely as the dose of carcinogen required, experiments 3,
13, 14 and 15 (Table V) suggest that C57 mice are ofthe order of 10 times as sensi-
tive as stock mice to threshold doses of benzpyrene when it is administered in
5 divided doses, but only about twice as sensitive when the dose is given in one
injection; experiments 9 and 13 suggest that the sensitivity of different lots of
stock mice can vary by something of the order of 6: 1 or more. Although the
benzpyrene dose varied in the ratio 1: 100 in experiments 5, 6, 7, the yield of
tumourswas muchthesame, suggestingthatthe cholesterol in theinjectionmaterial
was the active carcinogen and not the benzpyrene. In these three experiments
the incidence was about 6 per cent calculated on the number of mice at start, but
about double this figure when the calculation is based on the mice which survived
a minimum of 1 year and therefore were effective, (i.e. at risk). An incidence of
10-15 per cent would agree well with that obtaining in several of our experiments
where the mice developed a reasonable proportion oftumours when injected with
cholesterol (the frequently occurring incidence of about 10-15 per cent will be
further discussed in a forthcoming publication). This figure of 10-15 per cent can
now be contrasted with the results for experiments 10, 11, 12 where the incidence
was 0 per cent. As far as the data go, they suggest that the sensitivity ofdifferent
batches of mice can vary over a considerable range whether this sensitivity is
assayed by the use of cholesterol or by small doses of benzpyrene.
To extend the idea of possible contamination by benzpyrene a further step,
the following experiment was carried out: mice were injected with cholesterol
and arranged in groups of 4 in separate cages; to each cage was then added a
single mouse of a different colour (a coloured mouse with 4 white mice or a white
mouse with 4 coloured mice) which was painted biweekly with benzpyrene solu-
tion in the interscapular area during the whole course of the experiment. TheI. HIEGER
mice injected with cholesterol were thus in an environment contaminated with
benzpyrene, yet only in experiment A (Table VI) was there a large number of
sarcomas which would be attributed to benzpyrene. In this particular experiment,
the 11 injections of cholesterol were given at 4 weekly intervals concurrently with
the biweekly painting ofthe single mouse withbenzyprene. A possible explanation
of the results in experiment A is that at the injection of cholesterol some benz-
pyrene on the fur, transferred there by contact with the painted mouse, was
pushed through the skin into the subcutaneous layers. In a few cases papillomas
arose on the skin of the mice which had not been painted with benzpyrene but
had a cage-mate which was so treated.
TABLE VI.-Effect ofExposing Mice Injected with Cholesterol to an
Environment Contaminated with Benzpyrene
In each experiment below the mice were caged in groups of 5. Four mice
were for injection only, and the fifth for painting only (with benzpyrene).
Survivors
12 18 24
Strain Start (months) Sarcomas
A Injected 11 times with 10 per cent cholesterol in olive
oil at beginning of each of 11 months. In the 2nd and
3rd week of each month-biweekly painting . . stock . 80 42 16 12
B 4 injections (cholesterol) at fortnightly intervals, then
after a 3-week interval painting begun . . C57 40 30 26 3 0
C 4 injections (cholesterol) at fortnightly intervals, then
after a 3-week interval-painting begun. . . stock . 40 30 13 2 . 2
D 4 injections (cholesterol) at fortnightly intervals, then
after 4 months-painting begun. . . . stock 40 28 12 2 0
E Paint biweekly for 3 months only. Then after an in-
terval of 1 month, 4 fortnightly injections ofolive oil-
tristearin (5: 1). . . . . . stock . 40 12 2 - . 0
F Inject 4 times with an olive oil : tristearin mixture
(5 : 1), then after an interval of 3 weeks, biweekly
painting begun. . . . . stock 44 28 14 2 . 2
G Painted biweekly for 3 months. Then, after an interval
of 2 weeks given 4 injections of cholesterol. . . stock . 60 11 -. 0
EXPLANATION OF PLATES
FIG. 1.-Sarcoma induced at site ofinjection of purified cholesterol in olive oil. ~ stock
mouse. 16th month. x 65.
FIG. 2.-Same tumour as in Fig. 1. x 300.
FIG. 3.-Sarcoma induced at site of injection of purified cholesterol in olive oil. d stock
mouse. 18th month. x 65.
FIG. 4.-Same tumour as Fig. 3. x 300.
FIG. 5.-Sarcoma induced at site ofinjection of purified cholesterol in olive oil. 3 stock
mouse. 9th month. x 75.
FIG. 6.-Same tumour as in Fig. 5. X 300.
FIG. 7.-Tumour on left side of 9 stock mouse which had been injected on right side with
tristearin in olive nil. 19th month. x 90.
FIG. 8.-Same tumour as in Fig. 6. x 300.
FIG. 9.-Tumour on left side of $ stock mouse which had been injected on right side with
cholesterol in olive oil containing added 1 per cent turpentine. 19th month. x 90.
FIG. 10.-Same tumour as in Fig. 9. X 300.
FIG. 11.-Tumour on left side of c stock mouse which had been injected on right side with
cholesterol in olive oil. 15th month. x 90.
FIG. 12.-Same tumour as in Fig. 11. x 300.
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These data show that no very stringent precautions need to be taken to avoid
fictitious results due to contamination, since the mice in experiments B and C,
although in an environment contaminated with benzpyrene, did not develop
sarcomas in excess of what would be expected from the injection of cholesterol
per se. It is difficult to explain the appearance of the two sarcomas in experiment
F (Table VI) where no cholesterol but a mixture oftwo fats were used for injection
(olive oil and tristearin) in order to test the possible localising effect of lipoid
substances other than cholesterol.
(IV) In other laboratories, cholesterol has not produced tumours
Hartwell (1951) quotes 39 entries under the section dealing with tests for the
carcinogenicity of cholesterol; some details are given of the species of experi-
mental animal, vehicle and dose of cholesterol, site and route of administration,
duration of experiment, survival rate and yield of tumours. None of these 39
experiments gave positive results of the kind which are the criteria of the present
enquiry, i.e. spindle-celled sarcoma at the site of injection (sub-cutaneous) in
mice injected with large doses of cholesterol of the order of a minimum of 40 mg.
administered in lard or olive oil, in mice of stock or C57 strain which had a satis-
factory survival rate. However, Hartwell's compilation was not completely up
to date even in 1951 since he does not refer to the writer's experiments published
in 1947 where 11 sarcomas were obtained by the injection ofcommercial cholesterol
in 144 mice (Hieger, 1947).
As far as the author is aware, his experiments are almost the only ones giving
positive results in tests for the carcinogenic activity of cholesterol. Is the dis-
crepancy due to differences in the solvent, in the strain of mouse, in the duration
of the experiment or in the environmental conditions of the animals ? The role
played by the solvent in carcinogenesis by lipoid substances and steriods has not
yet been settled. Cholesterol of different degrees of purity has been found highly
active when administered in olive oil or in lard; Steiner (1941) reported that
mixtures of the unsaponifiable fractions of human liver with tricaprylin or with
sesame oil were strongly carcinogenic; Bischoff et al. (1955) tested oxidative
derivatives of cholesterol suspended in sesame oil with positive results. These
four oils (lard, olive oil, sesame oil and tricaprylin) can accordingly be considered
as suitable vehicles for testing carcinogens oflipoid or steroid type since the control
tests on the oils alone give a very low yield of tumours, namely, of the order of
2 per cent (TableI).
The choice ofthe strain of experimental mouse is probably an important factor
in affecting the response to lipoid carcinogens. Cholesterol in olive oil or in lard
has given an incidence of 10-15 per cent or more ofsarcomas inC57 mice, in mixed
commercial stock mice, and in the laboratory stock bred from a mixed commercial
stock.In an experiment on 100 mice of the CBA strain injected with commercial
cholesterol in olive oil, the yield of sarcomas was less, namely 2 per cent (Table
VII). Small series of C3H mice tested with the same solution proved refractory
and small series of mice of the MRC strain reacted positively.
Such differences of sensitivity of different strains of mice to cholesterol as a
carcinogen are not unexpected since variations of susceptibility to conventional
carcinogens (e.g. hydrocarbon type) are well known and an example is shown in
Table V. What is more difficult to explain is the frequently occurring fluctuations
in response exhibited by different batches of mice of the same genetic origin.
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Differences of sensitivity to carcinogens can easily be found when a miniimal
dosage of carcinogen is used but when an excessive dose of carcinogen is applied
(such as, say, a milligram or even a tenth of a milligram ofbenzpyrene) anything
but gross differences of sensitivity will be masked by the excess of carcinogen;
therefore, in order to reveal and assess the comparative sensitivity of different
groups of mice, the dose of carcinogen should be at threshold, or near threshold,
level. If the carcinogen is of an order of potency much below that of the hydro-
carbon carcinogens of the type of benzpyrene, it can be expected that even after
the application of large doses, only a fraction of the mice would react and the
conditions would be well suited for demonstrating variations of susceptibility
which are not likely to appear when hydrocarbon carcinogens are employed,
unless in minute doses. In Table VII are shown the fluctuations ofresponse when
mice ofC57 or stock strains were tested with pure or with commercial cholesterol.
The yield of sarcomas varied from 0-14 per cent or more in different batches of
mice. Experiments t and q (both groups injected with commercial cholesterol)
are of special interest: the origin of the mice was the same (a more complete
correspondence would have been achieved if the individual members of the two
groups had been thoroughly "shuffled "). Group q was housed in a room kept at
about 70° F. andwater was supplied inbulbs in the usual way: group t washoused
in cageswellsuppliedwithwoodwool, in aroomfacingnorthwherethetemperature
followed the external temperature but was not allowed to go below 40° F. and the
only water available to the mice was supplied in cabbage leaf. In experiment q
the yield of sarcomas was zero in 50 mice, in t it was 5 in 46 mice (initially)
amounting to an incidence of 16 per cent calculated on the survivors at one year.
These experiments suggest that environmental factors were of importance in
influencing the response to the carcinogen. A comparison of experiments s (pure
cholesterol) and q (commercial cholesterol) suggests that purified cholesterol
(Schwenk process, see Hieger (1957) for details) is more potent carcinogenically
than commercial cholesterol; but it must be noted that in experiment r no sar-
comas were induced in 54 stock mice with the olive oil preparation of pure chole-
sterol, whereas in n and o the incidences were 14 per cent in one case and was
calculated to have been the same theoretically in the other (Hieger, 1957). It is
very difficult to find any explanation of why the same, or very nearly the same,
preparation of cholesterol gives 14 per cent of sarcomas in stock mice in one
experiment and 0 per cent in another.
The conclusions to be drawn from the data shown in Table VII are that no
single variable-nor the purity of the cholesterol, nor chance contamination with
atmospheric carcinogens nor strain differences, nor solvent differences-can be
implicated as solely responsible for the fluctuations in carcinogen response; the
alternative explanation is that a combination of some genetic, congenital or
environmental factors (e.g. temperature and drinking water) are the effective
agents, but of course such an explanation has still to be proved adequate.
In Section III the range of variations in susceptibility to threshold doses of
benzpyrene was observed to be something of the order of 5: 1, if the sensitiveness
be regarded provisionally as proportional to the percentage yield of tumours and
inversely as the dose of carcinogen. Fluctuations of susceptibility of this order of
magnitude could explainwhy some batches ofmice do not react under the stimulus
of cholesterol as carcinogen; as a first approximation it is suggested that such
variations are due to the operation of the same factors which cause variations in
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the incidence of "spontaneous" neoplasia in mice, although of course, there is
no experimental evidence as yet for this idea. It will be recalled that Tannenbaum
and Silverstone (1957) showed that mere alterations in the calorific value of the
diet of mice could greatly influence the incidence of spontaneous mammary
cancer and of tumours induced with carcinogens.
TABLE VII.-Table Showing Incidence ofSarcomas in Mice After Subcutaneous
Injection with Cholesterol
No. of mice and
Pure or survivors % Calculated
commercial (months) Incidence on
Experi- Insti- (comm.) , -- Sar- on initial survivors
ment tute Room Strain Cholesterol Initial 12 18 24 comas No. at 1 year
a .C.B.. . C57 comm. .108 68 45 10. 10 . 9-3 14
b .. stock. ,, .45 18 3 5 3 . . . 28
c ,,. .MRC. ,, .20 16 8 2. 2. 10 .12
C57+ ~ d stock * pure 34 18 11 2 1. 3 . 6
ae .P.W.. non-C . C57 . comm. 60 28 14 3. 1 . 1-7 . 3-6
f .,, . ,,. stock ,, 70 38 18 2 3 . 4-3 . 7.9
g .,,.,,.,, ,, 65 57 41 11 3. 4-6 . 5.4
h . ,, C .,, ,, 100 75 45 10 8 . 8 . 10- 7
i . ,, . , . CBA 100 71 45 2 2 2 . 2-8
j .,, . non-C . C57 pure 172 126 81 20 . 5 . 2-9 4
k . ,, . ,, .,, . comm. .30 10 7 5 . 1 . 3-3 .10
I .,,.,,.,,. ,, 39 24 16 11 3 7.7 13
m . ,, C .,,. 75 46 26 3 4 5-5 . 8-7
n . .. stock . pure .115 66 22 10 11 . 9.5 . 14
o ,, non-C .,, ,, . 109 all t < 1 yr. 3 3 probably
(epidemic) much > 3
p .. ,, . ,, . comm. .53 27 11 0. 0. 0 .
q . C57 · . 50 3832 23 . 0 . 0
r .. ,,. stock. pure 53 25 12 2. 0. 0 -
s . ,, . ,,. C57 ,, 50 47 35 22 3 6 . 6-4
t ,, lowtem- C57 comm. 46 32 23 12 . 5 . 11 16
perature
u . ... stock. ,, .40 19 50 0 .0 . .
C.B. - Chester Beatty Research Institute, London. P.W. = Pollards Wood in Buckinghamshire,
20 miles out of London. Non-C -= Non-Carcinogen Room. Carcinogens of conventional type (e.g.
benzpyrene) were neither used nor kept in this room. C = Carcinogen room. In this room, besides
mice injected with cholesterol, were other series undergoing treatment with benzpyrene. Low-
temperature room = This room faces north; temperature not below 40°F. but otherwise follows
outside temperature. Water is supplied only as present in fresh cabbage leaf.
Dunn, Heston and Deringer (1956) reported that in the female mice in their
colony consisting of C3H strain bearing the mammary milk agent, C3Hf lacking
the agent, C57BL strain and F1 and backcross hybrids of these strains, a total
yield of 106 subcutaneous fibrosarcomas were found in 4049 mice (initially).
These workers quote Cloudman (1941) who, referring to a certain colony of mice
stated that "sarcomas were among the more common malignant tumours in the
subcutaneous regions, but there were no high-tumour stock, and it was unusual
to find an incidence of over 15 per cent." Dunn, Heston and Deringer's (1956)
results (106 tumours in 4049 female mice) represent a crude incidence of 21 per
cent sarcomas, but as the average latent period when the tumours occurred was
at the advanced age of 22-32 months, which was approximately the average long-
evity ofthe mice, the true incidence was very probably a multiple of 24 per cent,I. HIEGER
say 5 per cent or more, since a fair proportion were dead before reaching the latent
period and could not be considered at risk.
Some impression ofthe variations ofincidence in their experiments is conveyed
by the number of sarcomas in consecutive groups of C3Hf mice (Table VIII).
TABLE VIII.-Spontaneous Fibrosarcoma in C3Hf Mice
(Dunn, Heston and Deringer, 1956)
Number of . Number of
Genetic composition of foster mother mice sarcomas
(a) C3Hf mice foster-nursed on > C57 (100 per cent C57 chromatin:
0 per cent C3H chromatin) .. . . 81 . 3
(b) C3Hf mice foster-nursed on > Cross-bred (50 per cent C57 chro-
matin: 50 per cent C3H chromatin) . . 90 9
(c) C3Hf mice foster-nursed on >Cross-bred (25 per cent C57 chro-
matin: 75 per cent C3H chromatin) . . 64 . 0
It is very difficult to explain how the variations in the genetic composition of
the foster-mothers ofthe mice in experiments b and c was sufficient to change the
incidence of spontaneous sarcoma from a maximum of 10 to 0 per cent.
The foregoing considerations suggest that (1) at low intensity stimulus
(cholesterol as carcinogen, or threshold doses of benzpyrene or "spontaneous"
sarcoma) several factors together or separately can cause wide fluctuations of
incidence of sarcoma; (2) that of these factors, two can be identified namely the
"environment" and the genetic composition of the mice; (3) that alternatively
some other factors are operative, the nature of which is as yet unknown.
These 3 possibilities could explain the disagreement between the results of
tests on cholesterol and its oxidative derivatives which were used by Bischoff,
et. al. (1955) and by the writer. Bischoff et. al. (1955) and Fieser et al. (1955)
report that 6fl-hydroperoxy-A4-cholestene-3-one is a potent carcinogen, for it
gives sarcoma in over 60 per cent of Buffalo mice (Table II). In the tests
described in Table III this compound is shown to be as active as cholesterol, i.e.
giving a sarcoma incidence of 8-10 per cent but these experiments were carried
out onC57 mice. A batch ofBuffalo mice imported from the U.S. appeared healthy
on arrival but have not maintained this condition, they are very prone to mite
infestation (however, vigorous treatment with DDT and with benzyl-benzoate
seems to be effecting some improvement of the state of the skin). Bischoff and
Rupp (1946) find that this strain of mice is liable to spontaneous sarcoma, they
state " ... In previous experiments male mice observed for 20 months or more
developed a higher incidence of skin tumours; namely 10 per cent in 30 control
mice, and 23per cent in 30 males that had received oestrone." Perhaps the Buffalo
mice are specially sensitive to some carcinogens since their subcutaneous tissues
are prepared, as it were, for neoplasia, assuming that the two processes follow the
same path, but of course, their insensitivity to cholesterol as carcinogen would
remain unexplained.
The spontaneous subcutaneous sarcoma rate in the mice in the author's
laboratory must be very small indeed. An estimate ofthe incidence could be made
by a count of the sarcomas which have appeared on the left side of the animals.
All the injections of cholesterol, derivatives of cholesterol, lipoid fractions of
tissues and controls on solvents, were carried out on the right side. To date over
140 sarcomas have been recorded on the right side and 7 subcutaneous tumours
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on the left side, but the histological appearance of most of these 7 tumours is
rather different from that of the spindle-celled sarcomas induced at the site of
injection by cholesterol and by the lipoid tissue-extracts which are very similar
histologically to the sarcomas produced by hydrocarbon-type carcinogens. Con-
sequently, it is doubtful if there is any appreciable incidence of spontaneous
spindle-celled sarcoma in our stocks. Photomicrographs of these two kinds of
subcutaneous tumour are shown in Fig. 1-12.
Guerin (1954) states that in his colony of 6000 mice the most frequently occur-
ring spontaneous tumour was not mammary cancer but connective tissue tumours
of the reticuloendothelial system (275 cases equivalent to an incidence of 4 per
cent). Thirteen spontaneous sarcomas were found, 12 of which were "fusohistio-
cytaire "; the average tumour age was about 20 months.
V. Role ofheating as apossible contributoryfactor in carcinogenic activity ofsolution
of cholesterol.
Cholesterol as large dense flakes dissolves slowly on heating with olive oil at
water bath temperature and when a large series of mice (say 50-100) are to be
injected in turn, the time required for total heating may be approximately 2 hours.
During that time chemical changes may occur in the solution; indeed the solu-
tions and even oils alone (particularly sesame oil and lard) after being heated on
the water bath show a much increased spectroscopic absorption in the ultra-
violet region of the spectrum.
Since our experiments with cholesterol administered in aqueous medium (i.e.
finely ground cholesterol in suspension in 4 per cent gelatin gel) have so far given
negative results, the criticism has been put forward that chemical changes taking
place or initiated during the heating of the cholesterol with oil could explain the
carcinogenic activity of the solution and the inactivity ofthe non-oily suspension.
However, there is a total lack of experimental evidence for (and some facts can
be advanced which do not support) this possibility. The control tests on the oily
solvents alone (olive oil and lard) comprised over 1,000 mice which produced 5
sarcomas only. The oils were heated on the water bath before injection but since
they were either liquid or melted very quickly, the time of heating was mainly
dependent on the number of mice being injected and therefore the total heating
could have been less than in the experiments with solutions of cholesterol: but
since the total number of injections was greater in the control series because oil
alone is more readily dispersed in the tissues, the effective total heating was prob-
ably not very different in the two cases.
To pursue the same line of argument further, it would now be necessary to
postulate that the presence of cholesterol during the heating is necessary for
inducing the hypothetical chemical change. Sarcomas were not obtained in
experiments set up to test this possibility (Table IX). Positive results must take
precedence over negative results; the latter may be due to an insensitive batch
of mice or to environmental conditions which are not conducive to sarcoma pro-
duction: some solutions of cholesterol heated in the usual way have not produced
sarcoma in mice, and if for the sake of argument it be assumed that the agent is
indeed formed during the heating, its hypothetical presence therefore is not as
decisive as e.g. the sensitivity of the mice or the environmental factor. There
seems no reason for multiplying the number of unknowns, and the formation of
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a carcinogen by heating oil and cholesterol at water bath temperature remains
at present unproved, what evidence exists is against such possibility.
TABLE IX.-Results ofInjecting (1) Heated Olive Oil; (2) Heated Solution
of Cholesterol (10 per cent) in Olive Oil
Survivors
(months)
Number of No. of
Preparation mice Strain 12 18 24 Sarcomas
(1) .12 c7 50 35 17 6 0 38 . stock
(2) 3317 C57 6 50 35 15 4 0 33 stock
(3) 14 C357 s 50 .38 16 9 * 1
36 stock
(1) Olive oil heated, with access of air, 75 hours on boiling water bath.
(2) 10 per cent cholesterol + 90 per cent olive oil heated with access of air, 75 hours on
boiling water bath.
(3) Olive oil heated, with access of air, 76 hours on boiling water bath then 10 per cent
cholesterol added without prolonged further heating.
SUMMARY AND CONCLUSIONS
1. Over 140 sarcomas in mice have been induced by the subcutaneous injec-
tion of oily solutions of (1) the unsaponifiable fraction of human tissue, or (2) of
cholesterol.
2. Purified cholesterol is at least as potent as the commercial product before
purification.
3. In one experiment on highly purified cholesterol, 11 sarcomas developed in
115 mice ofwhich 66 lived over 1 year. Ifthe mice which died early and were not
at risk be omitted the incidence amounts to 14 per cent.
4. One of the oxidative derivatives of cholesterol reported by Fieser and
Bischoff to be carcinogenic has given positive results when tested in the writer's
laboratory. The most active of their compounds, 6f,-hydroperoxy-A4-cholestene-
3-one, which is reported by Bischoff to give 60 per cent sarcomas in Buffalo mice,
has induced sarcoma in 4 out of 50 treated C57 mice.
5. The degree of response to cholesterol as carcinogen has been found to
fluctuate widely. It is suggested that such variations ofsensitiveness are revealed
by carcinogenic stimuli of low-intensity, and are linked with congenital and
environmental factors.
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